License

Besides the authorization to manufacture a human medicinal product in accordance with § 13 (1) of the German Medicinal Products Act (AMG) for autologous mesenchymal stem cells, TICEBA is also authorized to manufacture a medicinal product for allogeneic mesenchymal as well as allogeneic limbal ABCB5 + stem cells following a recent extension.

TICEBA also possesses the license within the meaning of §20b (1 and 2), §20c, and §72b of the AMG for the authorization for the extraction of tissue, the treatment or processing, preservation, testing, storage, import of tissue or tissue preparations.

All described activities are carried out by TICEBA in accordance with the authoritative European and German instructions in compliance with Good Manufacturing Practice (GMP).

Under these strict conditions, your stored skin cells can be used in the case of need as raw material for the manufacturing of an autologous (from the patient himself) or allogeneic (from a donor) medicine.

News
License

Besides the authorization to manufacture a human medicinal product in accordance with § 13 (1) of the German Medicinal Products Act (AMG) for autologous mesenchymal stem cells, TICEBA is also authorized to manufacture a medicinal product for allogeneic mesenchymal as well as allogeneic limbal ABCB5 + stem cells following a recent extension. For more information click HERE.

Clinical Trial

Together with our subsidiary RHEACELL we are recruiting patients with the indication chronic venous ulcer (CVU) for the clinical trial in phase 1/2a. For more information click HERE.

The Story of Stem Cells

Review our category "The Story of Stem Cells" with the newest topic "Stem cells in wound healing" HERE.

Newsletter